๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases

โœ Scribed by Sue McDiarmid; Robert G. Gish; Simon Horslen; George V. Mazariegos

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
74 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Model for end-stage liver disease (MELD)
Model for end-stage liver disease (MELD) exception for polycystic liver disease
โœ Luis Arrazola; Dilip Moonka; Robert G. Gish; Gregory T. Everson ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB

Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh

Model for end-stage liver disease (MELD)
Model for end-stage liver disease (MELD) exception for cystic fibrosis
โœ Simon Horslen; Stuart Sweet; Robert G. Gish; Ross Shepherd ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 58 KB ๐Ÿ‘ 1 views

Cystic fibrosis (CF) is a multisystem disease caused by mutations in a single gene (cystic fibrosis transmembrane conductance regulator) and is the most frequent potentially fatal inherited condition in whites, occurring in 1 in 2,000 births. Progressive pulmonary disease is the major contributor to